Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Clearside Biomedical Inc’s stock clocked out at $0.34, down -2.86% from its previous closing price of $0.35. In other words, the price has decreased by -$2.86 from its previous closing price. On the day, 0.8 million shares were traded. CLSD stock price reached its highest trading level at $0.3554 during the session, while it also had its lowest trading level at $0.331.
Ratios:
To gain a deeper understanding of CLSD’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.87 and its Current Ratio is at 3.87.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 24 ’25 when Thorp Clay bought 15,000 shares for $0.92 per share. The transaction valued at 13,800 led to the insider holds 176,141 shares of the business.
Chong Ngai Hang Victor bought 36,500 shares of CLSD for $36,500 on Nov 01 ’24. The Chief Medical Officer now owns 100,000 shares after completing the transaction at $1.00 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLSD now has a Market Capitalization of 26387314 and an Enterprise Value of 73246320. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.33. Its current Enterprise Value per Revenue stands at 17.582 whereas that against EBITDA is -3.402.
Stock Price History:
The Beta on a monthly basis for CLSD is 2.12, which has changed by -0.70265484 over the last 52 weeks, in comparison to a change of 0.18189907 over the same period for the S&P500. Over the past 52 weeks, CLSD has reached a high of $1.65, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is -35.75%, while the 200-Day Moving Average is calculated to be -58.89%.
Shares Statistics:
It appears that CLSD traded 4.50M shares on average per day over the past three months and 717700 shares per day over the past ten days. A total of 78.50M shares are outstanding, with a floating share count of 62.02M. Insiders hold about 21.00% of the company’s shares, while institutions hold 13.88% stake in the company. Shares short for CLSD as of 1755216000 were 1799248 with a Short Ratio of 0.40, compared to 1752537600 on 162565. Therefore, it implies a Short% of Shares Outstanding of 1799248 and a Short% of Float of 2.33.
Earnings Estimates
Investors are keenly observing as 1.0 analysts analyze and rate the current performance of Clearside Biomedical Inc (CLSD) in the stock market.The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.18 and -$0.42 for the fiscal current year, implying an average EPS of -$0.3. EPS for the following year is -$0.32, with 6.0 analysts recommending between -$0.15 and -$0.48.
Revenue Estimates
A total of 3 analysts have provided revenue estimates for CLSD’s current fiscal year. The highest revenue estimate was $3.4M, while the lowest revenue estimate was $2.8M, resulting in an average revenue estimate of $3.19M. In the same quarter a year ago, actual revenue was $1.66M